<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03329976</url>
  </required_header>
  <id_info>
    <org_study_id>KAUFFMANN PHRCI 2016</org_study_id>
    <nct_id>NCT03329976</nct_id>
  </id_info>
  <brief_title>Validation of a Prognostic Score for Good Visual Recovery at One Year Following Combined Surgery for Cataract and Idiopathic Epiretinal Membrane</brief_title>
  <acronym>PROCATMER</acronym>
  <official_title>Validation of a Prognostic Score for Good Visual Recovery at One Year Following Combined Surgery for Cataract and Idiopathic Epiretinal Membrane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of idiopathic epiretinal membranes (ERM) in people over 50 is estimated at 6&#xD;
      to 19%. Even though most cases show very few symptomats, they may induce alterations of the&#xD;
      underlying retina and lead to visual impairment likely to greatly diminish quality of life in&#xD;
      patients. Thanks to the ever-improving quality of vitreo-retinal surgery, ablation of these&#xD;
      membranes is a frequent and safe procedure allowing a functional gain in the majority of&#xD;
      cases. Given the increasing prevalence in the population concerned and the accelerated ageing&#xD;
      of the lens after vitrectomy, cataract surgery is often associated with removal of the&#xD;
      membrane. On the basis of a study in 142 patients, it was possible to identify clinical and&#xD;
      morphological prognostic factors and to inclure them in a score to assess the chances of&#xD;
      complete functional recovery at one year following the procedure . Age of the patient, the&#xD;
      duration of symptoms, initial visual acuity and the quality of the junction between external&#xD;
      and internal segments of photoreceptors in optic coherence tomography (OCT) appeared as&#xD;
      significantly related to visual results. Using this score in a new prospective cohort would&#xD;
      allow the investigators to make it a reliable and easy-to-use tool at the service of&#xD;
      ophthalmologist surgeons and their patients and would provide scientific confirmation of the&#xD;
      interest of earlier surgery in this disease. It would also allow the investigators to define&#xD;
      in a validated and reproducible manner, a threshold for an ndication for ERM surgery, which&#xD;
      is currently based on relatively subjective criteria mostly related to visual acuity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2018</start_date>
  <completion_date type="Anticipated">October 2025</completion_date>
  <primary_completion_date type="Anticipated">October 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>scale of monoyer at 5 meter</measure>
    <time_frame>over the 12 months of follow-up</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Surgery for Cataract</condition>
  <condition>Surgery for and Idiopathic Epiretinal Membrane</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <description>any person about to undergo combined surgery for cataract and ERM</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>measurement of visual acuity</intervention_name>
    <description>complete ophthalmologic examination of a macular SD-OCT, a fundus of eye, evaluation of the vision of contrasts (Pelli-Robson test) and quantification of metamorphopsies (M-Charts);</description>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        any person about to undergo combined surgery for cataract and ERM&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting idiopathic ERM visible on SD-OCT;&#xD;
&#xD;
          -  Indication for combined cataract and ERM surgery in a context of a fall in visual&#xD;
             acuity or disabling metamorphopsia;&#xD;
&#xD;
          -  Patients who have provided verbal consent;&#xD;
&#xD;
          -  Age ≥ 40 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with secondary ERM (Diabetes WITH a history of diabetic retinopathy or&#xD;
             maculopathy, occlusion of the retinal veins, uveitis intermediate/posterior uveitis or&#xD;
             retinal tear/detachment in the studied eye;&#xD;
&#xD;
          -  Patient présentant toute autre maculopathie ou neuropathie optique ;&#xD;
&#xD;
          -  Patient presenting severe myopia (spherical equivalent ≥ 6 diopters or axial length ≥&#xD;
             26 mm) ;&#xD;
&#xD;
          -  Patients presenting any other ophthalmological disease independent of the ERM and&#xD;
             likely to limit visual acuity&#xD;
&#xD;
          -  Patients who have already undergone vitrectomy in the studied eye;&#xD;
&#xD;
          -  Non-visible or poorly visible fundus due to a cloudy vitreous (Signal on OCT Cirrus&#xD;
             &lt;5, Quality score on OCT Spectralis &lt; 20, signal trend index on OCT Optovue &lt; 30)&#xD;
&#xD;
          -  Patients without national health insurance cover&#xD;
&#xD;
          -  Pregnant or breast-feeding women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yann KAUFFMANN, MD</last_name>
    <phone>3 80 29 51 73</phone>
    <phone_ext>+33</phone_ext>
    <email>yann.kauffmann@hotmail.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yann KAUFFMANN, MD</last_name>
      <phone>3 80 29 51 73</phone>
      <phone_ext>+33</phone_ext>
      <email>yann.kauuffmann@hotmail.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 13, 2017</study_first_submitted>
  <study_first_submitted_qc>October 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

